<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Specificity of TdT5 as a marker for ALL was evaluated by determining its activity in cells from <z:mpath ids='MPATH_458'>normal</z:mpath> control subjects and from 35 pediatric patients with ALL, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> and disseminated Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated the DNA polymerase activity, cell surface phenotypes (E rosettes, EAC rosettes, Smlg and la-like, HTLA and <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">cALL</z:e> antigens), and hematological and cytochemical characteristics in both the <z:mpath ids='MPATH_458'>normal</z:mpath> and patient groups </plain></SENT>
<SENT sid="2" pm="."><plain>DNA polymerase alpha + beta and DNA polymerase gamma activity were indiscriminately high in <z:hpo ids='HP_0000001'>all</z:hpo> immature cells as found in ALL, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and phytohemagglutinin-stimulated <z:mpath ids='MPATH_458'>normal</z:mpath> lymphocytes, when compared to mature leukocytes found in <z:mpath ids='MPATH_458'>normal</z:mpath> individuals or in patients whose <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> was in remission </plain></SENT>
<SENT sid="3" pm="."><plain>High TdT activity was found in 24 of 26 T and non-T/non-<z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B ALL</z:e> patients in active phase as well as in two of three <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> patients one of whom had Auer rods </plain></SENT>
<SENT sid="4" pm="."><plain>Thus, TdT, although valuable for monitoring ALL patients, may have limitations in separating <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> from ALL </plain></SENT>
</text></document>